In December, 2007, a study titled “[Use of SSRIs during pregnancy and possible consequences for the development of the child].” published in Nederlands tijdschrift voor geneeskunde (or, “Dutch Journal of Medicine”) by C.N. van der Veere et al discusses poor neonatal outcomes linked to SSRI use in pregnancy.
The authors of this short piece state that “Infants of depressed mothers are at increased risk for developing cognitive and behavioural problems”, noting that “Medication is often prescribed for pregnant women suffering from a major depression”, “Approximately 2% of Dutch pregnant women is using a selective serotonin reuptake inhibitor (SSRI)” and “SSRIs cross the placenta easily.” (emphasis added)
van der Veere et al. (2007) write that with for children exposed to SSRI drugs before birth, “In the postnatal period, increased incidence of respiratory distress, feeding and digestive disturbances, irritability and convulsions, and admission to a neonatal intensive care unit have been described.” Further, “Animal studies have shown permanent changes in specific parts of the brain and altered behaviour in adulthood after perinatal exposure to SSRIs.” (emphasis added)
Because the manufacturers of many SSRI drugs have failed time and again to warn women of these risks, thousands of SSRI birth defect lawsuits have been filed in recent years.
If you or a loved one used SSRIs and gave birth to a child with a birth defect or who suffered perinatal complications, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of SSRI birth defect lawyers at the information provided below. We have the compassion, resources, and experience required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529